Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1601 results

Treating severe restenosis of a 20-mm balloon-expanding valve after a transapical approach with a risk of coronary obstruction

05 Nov 2025

In this challenging redo TAVI case, an 87-year-old woman presented with severe bioprosthetic valve restenosis and advanced heart failure symptoms, eight years after a previous transapical implantation.

Her frailty, prior surgical approach, and complex anatomy—with low coronary heights and a stent frame extending beyond the sinotubular junction—posed...

Sasho Stanisavljevikj

Author

Sasho Stanisavljevikj
Rumman

Author

Abu Rumman
Jens Papenfuss

Author

Jens Papenfuss

Author

Christian Jacob
Alexander Staudt

Author

Alexander Staudt
Christian Fahje Klopsch

Author

Christian Fahje Klopsch
Treating severe restenosis of a 20-mm balloon-expanding valve after a transapical approach with a risk of coronary obstruction

Long-term follow-up of the PARTNER 3 Low-Risk randomised trial: seven-year clinical and echocardiographic outcomes

27 Oct 2025

Mirvat Alasnag interviews Michael J. Mack on the PARTNER 3 Low-Risk randomised trial he presented at TCT 2025 in San Francisco.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Michael Mack

Author

Michael Mack
Long-term follow-up of the PARTNER 3 Low-Risk randomised trial: seven-year clinical and echocardiographic outcomes

Unusual and high-stakes interventions

11 Oct 2025 – From AICT-AsiaPCR 2025

This session presents a series of unusual and high-stakes interventional cardiology cases that challenge conventional approaches. It includes critical scenarios such as narrow escapes from fatal outcomes, innovative solutions like complete percutaneous repair of adult tetralogy of Fallot, and management of valve complications, providing valuable insights...

Calcium modification and atherectomy

11 Oct 2025 – From AICT-AsiaPCR 2025

This session addresses the challenges of calcium modification and atherectomy in complex coronary interventions. It features case studies on stent deformation, advanced calcium modification strategies including orbital and laser atherectomy, imaging-guided approaches, and management of complications such as stent dislodgement, offering comprehensive insights into contemporary techniques...

Valve and structural: challenges and innovations

11 Oct 2025 – From AICT-AsiaPCR 2025

This session explores innovative approaches and challenges in valve and structural interventions, including expanding transcatheter techniques for ruptured sinus of Valsalva closure and prophylactic chimney stenting in high-risk TAVI patients. It also presents long-term outcomes of left main PCI according to stenting methods, comparative strategies in...

TAVI and aortic valve procedures

11 Oct 2025 – From AICT-AsiaPCR 2025

Focusing on transcatheter aortic valve interventions, this session covers a broad spectrum of complex cases including emergent TAV-in-SAV procedures, management of severely calcified bicuspid valves, zero-contrast TAVI techniques, and strategies for hostile anatomies. It provides valuable insights into procedural planning and follow-up to optimize patient care...

Artificial intelligence and innovations in interventional cardiology

10 Oct 2025 – From AICT-AsiaPCR 2025

Explore the transformative role of artificial intelligence and robotics in interventional cardiology. This session covers big data fundamentals, bridges the gap between emerging technologies and clinical practice, and discusses AI-enhanced decision-making and robotic applications in cardiovascular interventions.

Artificial intelligence and innovations in interventional cardiology

Redefining precision and performance in TAVI: advancing clinical outcomes with the Evolut FX+ system

10 Oct 2025 – From AICT-AsiaPCR 2025

Delve into advanced transcatheter aortic valve implantation (TAVI) with the Evolut FX plus system, focusing on its application in patients with small annulus and coronary artery disease (CAD). This session details step-by-step deployment, patient selection, imaging analysis, and highlights the distinctions from the previous Evolut R...

Redefining precision and performance in TAVI: advancing clinical outcomes with the Evolut FX+ system

Best Clinical Cases of AICT-AsiaPCR 2025

10 Oct 2025 – From AICT-AsiaPCR 2025

This session showcases the best clinical cases from AICT-AsiaPCR 2025, highlighting complex scenarios such as post-trauma ST-elevations, transcatheter aortic valve implantation complexities, CTO-PCI in high-bleeding-risk patients, and challenging device retrievals. It emphasizes clinical decision-making and innovative interventional techniques in diverse cardiac pathologies.

Best Abstracts of AICT-AsiaPCR 2025

10 Oct 2025 – From AICT-AsiaPCR 2025

This session showcases the best abstracts from AICT-AsiaPCR 2025, presenting cutting-edge research and clinical advancements in interventional cardiology. Topics include comparative evaluations of FFR techniques, predictive imaging markers, mechanical support in cardiogenic shock, novel diagnostic approaches, access strategies, TAVR outcomes, thrombectomy impact, STEMI management insights, and...

Redefining precision and performance in TAVI: advancing clinical outcomes with the Evolut FX+ system

10 Oct 2025 – From AICT-AsiaPCR 2025

Delve into advanced transcatheter aortic valve implantation (TAVI) with the Evolut FX plus system, focusing on its application in patients with small annulus and coronary artery disease (CAD). This session details step-by-step deployment, patient selection, imaging analysis, and highlights the distinctions from the previous Evolut R...

PCR @ TCT 2025 - Get the international perspective!

15 Oct 2025

Thanks to the contribution of a team of interventional cardiologists from around the globe, get the international perspective on Late-breaking Clinical Trials and Science released at TCT 2025 - check out the list below.

PCRonline @ TCT 2025 - get the international perspective!

Second valve strategies with SAPIEN 3 Ultra RESILIA

30 Sep 2025 – From PCR Gulf Valves 2025

Gain key insights into managing second valve interventions with the SAPIEN 3 Ultra RESILIA system.
This session helps you anticipate and address complex scenarios such as mitral valve-in-valve, TAV-in-SAV, and valve-in-valve-in-valve procedures. Learn from expert case discussions that explore procedural strategies, technical challenges, and best practices to...

Second valves strategies with SAPIEN 3 Ultra RESILIA - Regional insights

Abstracts and challenging clinical cases

30 Sep 2025 – From PCR Gulf Valves 2025

Engage with a dynamic collection of abstracts and challenging clinical cases that highlight the latest advances and investigative studies in interventional cardiology. Topics include innovative approaches to aortic stenosis management, AI-powered procedural planning, hemodynamic insights beyond traditional imaging, and complex valve interventions, providing a comprehensive overview...

Abstracts and challenging clinical cases

Complex femoral access for TAVI in bicuspid aortic stenosis - LIVE Case

30 Sep 2025 – From PCR Gulf Valves 2025

A 74-year-old male with a history of multiple PCIs, peripheral arterial disease, and type 2 DM presented with symptomatic bicuspid aortic stenosis and preserved LV function.

A 26 mm Myval valve was implanted via right femoral artery access, with right radial secondary access, following predilatation with a...

Complex femoral access for TAVI in bicuspid aortic stenosis - LIVE Case

Improving aortic stenosis diagnostic accuracy

30 Sep 2025 – From PCR Gulf Valves 2025

Enhance your diagnostic accuracy in aortic stenosis through this targeted session. Learn to differentiate among various types of aortic stenosis, avoid common echocardiographic diagnostic errors, and master transesophageal echocardiography (TEE) measurement techniques to effectively guide transcatheter aortic valve implantation (TAVI), especially in emergency settings.

Step-by-step TAVI for mixed bicuspid aortic valve disease - LIVE Case

30 Sep 2025 – From PCR Gulf Valves 2025

A 65-year-old female with a history of diabetes and moderate left ventricular dysfunction (LVEF 50%) presented with symptomatic severe bicuspid aortic stenosis associated with moderate-to-severe aortic regurgitation. A 26 mm Sapien Resilia valve was implanted under local anesthesia via femoral artery access, with right radial secondary...

Step-by-step TAVI for mixed bicuspid aortic valve disease - LIVE Case

Intervening in aortic regurgitation: are we finally there?

30 Sep 2025 – From PCR Gulf Valves 2025

Explore the evolving landscape of transcatheter treatment for aortic regurgitation in this informative session. Understand the anatomical and clinical criteria essential for selecting candidates for transcatheter therapy, review the latest device options supported by real-world and investigational data, and learn to navigate procedural challenges with advanced...

Intervening in aortic regurgitation: are we finally there?

Most impactful trials in structural heart disease 2024/2025

30 Sep 2025 – From PCR Gulf Valves 2025

Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...

Most impactful trials in structural heart disease 2024/2025

Step-by-step TAVI in bicuspid aortic stenosis - LIVE case

29 Sep 2025 – From PCR Gulf Valves 2025

A 67-year-old woman with a history of atrial fibrillation and normal LV function presented with symptomatic paradoxical aortic valve stenosis. A 23 mm Sapien Resilia valve was implanted following predilatation with a 15 mm semi-compliant balloon.

LIVE Educational Case from Prince Sultan Cardiac Center - Riyadh, Saudi...

Step-by-step TAVI in bicuspid aortic stenosis - LIVE case